ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag hiv vaccine culture disease medicine

DNA molecule.
Finding DNA Tags in AAV Stacks
Mariella Bodemeier Loayza Careaga, PhD | Mar 7, 2024 | 8 min read
Ten years ago, scientists put DNA barcodes in AAV vectors, creating an approach that simplified, expedited, and streamlined AAV screening. 
a newly hatched mosquito sits on top of water, with its discarded cocoon floating below
In Vitro Malaria Sporozoite Production May Lead to Cheaper Vaccines
Katherine Irving | Jan 20, 2023 | 4 min read
A method for culturing the infectious stage of the Plasmodium lifecycle could increase malaria vaccine production efficiency by tenfold, study authors say.
“Public” T-Cell Receptors From Resistant People Fend Off HIV
Shawna Williams | Jun 8, 2018 | 4 min read
The receptors, found in so-called elite controllers who don’t need medications to keep the virus in check, suggest a new path toward immunotherapy.
COVID-19, SARS-CoV-2, coronavirus, pandemic, pseudovirus, chimeric virus, disease & medicine, techniques, HIV, VSV, vaccine, variants, mutations
What Pseudoviruses Bring to the Study of SARS-CoV-2
Amanda Heidt | Feb 16, 2021 | 7 min read
Engineered viruses that don’t replicate provide a tractable model for scientists to safely study SARS-CoV-2, including research into vaccine efficacy and emerging variants.
The secret of HIV control
Andrea Gawrylewski | Dec 3, 2008 | 2 min read
The immune tricks that keep HIV in check in long term non-progressors (LTNPs) -- people who carry the virus but don't get AIDS -- have been a mystery for decades. It turns out that T cells in LTNPs destroy the virus by punching holes in infected cells and injecting a strong dose of apoptotic proteins, according to a study to be published in the December 19th issue of Immunity. "This study brings us closer to a potential vaccine or cure for AIDS," linkurl:Guido Silvestri;http://www.med.upenn.edu
New Weapons Against HIV
Ricki Lewis | Oct 1, 2001 | 8 min read
As the AIDS pandemic enters its third decade, viral resistance is beginning to counter the success of "highly active antiretroviral treatment" (HAART), the multidrug cocktails introduced in 1996. "Viral resistance is a significant problem, particularly for patients who began therapy in the pre-protease inhibitor era and who developed resistance to multiple reverse transcriptase inhibitors," says Robert Schooley, a professor of infectious diseases at the University of Colorado Health Sciences Cen
False-colored micrograph of Mycobacterium tuberculosis
Tuberculosis: The Forgotten Pandemic
Anthony King | Jul 1, 2021 | 10+ min read
This month marks the 100-year anniversary of BCG, still the only approved vaccine against the lethal pathogen. But there are new vaccines for this wily foe on the horizon.
Dendritic Cells Offer Potential Treatments For Cancer, HIV
Harvey Black | Jan 18, 1998 | 7 min read
HIV STUDIES: Rockefeller's Melissa Pope is investigating dendritic cell-T cell fusions with an eye toward potential strategies for interrupting HIV replication. Dendritic cells-highly specialized immune-system cells that can trigger T cells to fight infections-are being intensively studied as potential cancer vaccines. Researchers also are investigating these cells to understand their role in initiating HIV infection and for possible use in a vaccine for HIV. Dendritic cells are found in almo
How Some Vaccines Protect Against More than Their Targets
Shawna Williams | Nov 1, 2020 | 10+ min read
As researchers test existing vaccines for nonspecific protection against COVID-19, immunologists are working to understand how some inoculations protect against pathogens they weren’t designed to fend off.
adam kucharski the rules of contagion
Connecting the DOTS
Adam Kucharski | Aug 18, 2020 | 3 min read
The four factors that drive contagion

Run a Search

ADVERTISEMENT